Free Communications - Vaccines 5

11:25 AM • FC 18-01 • Impact of a single-cohort HPV vaccination strategy with quadrivalent vaccine in northeast Spain: population-based analysis of genital warts in men and women > M. Maria Brotons 11:36 AM • FC 18-02 • What is the difference in risk between unvaccinated and vaccinated women against human papillomavirus > E. Emi Naslazi 11:47 AM • FC 18-03 • Type-specific human papillomavirus prevalence in the north of Mexico, a 10 year study and relation with HPV vaccine coverage > J. JOSE Tiran Saucedo 11:58 AM • FC 18-04 • PUBLIC HEALTH AND ECONOMIC IMPACT OF HPV VACCINATION IN THE PORTUGUESE NATIONAL IMMUNIZATION PROGRAM > P. Paula Ambrosio 12:09 PM • FC 18-05 • HPV seroprevalence and genital HPV infections in a cohort of young women in the Netherlands seven years post-vaccination > J. Joske Hoes 12:20 PM • FC 18-06 • Extinction of HPV 6 and genital warts in a population with suboptimal HPV vaccine coverage > A. Agnieszka Denecke 12:31 PM • FC 18-07 • Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017 > M. Marta Checchi